Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
49.60
-1.02 (-2.02%)
Nov 19, 2026, 4:00 PM EST - Market closed
PBH Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,155 | 1,085 | 1,137 | 1,125 | 1,128 | 1,087 |
Other Revenue | 12.14 | 3.96 | 1.18 | 0.31 | 0.11 | 0.04 |
| 1,167 | 1,089 | 1,138 | 1,125 | 1,128 | 1,087 | |
Revenue Growth | 5.10% | -4.31% | 1.10% | -0.21% | 3.76% | 15.21% |
Cost of Revenue | 525.81 | 482.79 | 494.42 | 492.79 | 494.88 | 458.94 |
Gross Profit | 641.27 | 605.91 | 643.35 | 632.57 | 632.84 | 627.87 |
Selling, General & Admin | 296.19 | 265.23 | 263.93 | 259.47 | 252.42 | 259.7 |
Operating Expenses | 332.85 | 296.5 | 294.11 | 290.14 | 285.04 | 291.79 |
Operating Income | 308.42 | 309.41 | 349.24 | 342.43 | 347.8 | 336.08 |
Interest Expense | -66.07 | -42.34 | -47.63 | -67.16 | -69.16 | -64.29 |
Other Non Operating Income (Expenses) | -11.21 | -9.57 | -4.95 | 0.76 | -2.34 | -1.05 |
EBT Excluding Unusual Items | 231.14 | 257.5 | 296.66 | 276.03 | 276.3 | 270.74 |
Merger & Restructuring Charges | -17.21 | - | - | - | - | -5.1 |
Impairment of Goodwill | - | - | - | - | -48.8 | -0.3 |
Asset Writedown | - | - | -12.47 | - | -321.42 | -0.76 |
Other Unusual Items | -1.36 | - | - | - | - | -2.12 |
Pretax Income | 212.58 | 257.5 | 284.19 | 276.03 | -93.92 | 262.46 |
Income Tax Expense | 57.48 | 67.2 | 69.58 | 66.69 | -11.61 | 57.08 |
Net Income | 155.1 | 190.3 | 214.61 | 209.34 | -82.31 | 205.38 |
Net Income to Common | 155.1 | 190.3 | 214.61 | 209.34 | -82.31 | 205.38 |
Net Income Growth | -22.78% | -11.33% | 2.52% | - | - | 24.71% |
Shares Outstanding (Basic) | 48 | 48 | 50 | 50 | 50 | 50 |
Shares Outstanding (Diluted) | 48 | 49 | 50 | 50 | 50 | 51 |
Shares Change | -4.10% | -2.72% | -0.19% | 0.58% | -1.87% | 0.47% |
EPS (Basic) | 3.26 | 3.93 | 4.32 | 4.21 | -1.65 | 4.09 |
EPS (Diluted) | 3.25 | 3.91 | 4.29 | 4.17 | -1.65 | 4.04 |
EPS Growth | -19.65% | -8.86% | 2.88% | - | - | 24.31% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 214.22 | 246.45 | 243.29 | 239.38 | 221.93 | 250.28 |
Free Cash Flow Per Share | 4.49 | 5.06 | 4.86 | 4.77 | 4.45 | 4.92 |
Gross Margin | 54.95% | 55.65% | 56.55% | 56.21% | 56.12% | 57.77% |
Operating Margin | 26.43% | 28.42% | 30.70% | 30.43% | 30.84% | 30.92% |
Profit Margin | 13.29% | 17.48% | 18.86% | 18.60% | -7.30% | 18.90% |
Free Cash Flow Margin | 18.36% | 22.64% | 21.38% | 21.27% | 19.68% | 23.03% |
EBITDA | 345.08 | 340.68 | 379.41 | 373.1 | 380.43 | 368.17 |
EBITDA Margin | 29.57% | 31.29% | 33.35% | 33.15% | 33.73% | 33.88% |
D&A For EBITDA | 36.66 | 31.27 | 30.17 | 30.68 | 32.63 | 32.09 |
EBIT | 308.42 | 309.41 | 349.24 | 342.43 | 347.8 | 336.08 |
EBIT Margin | 26.43% | 28.42% | 30.70% | 30.43% | 30.84% | 30.92% |
Effective Tax Rate | 27.04% | 26.10% | 24.48% | 24.16% | - | 21.75% |
Revenue as Reported | 1,167 | 1,089 | 1,138 | 1,125 | 1,128 | 1,087 |
Advertising Expenses | - | 148.78 | 155.72 | 153.32 | 145.06 | 157.34 |